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1. Introduction
Urothelial bladder cancer is a rare presentation in 
young individuals, preferably below 40 years of age with 
reported incidence rate of around 0.1% to 0.4% in the 
first two decades of life and majority of patients are above 
60 years of age at the time of diagnosis [1]. Worldwide, 
bladder cancer ranks at 11th position with incidence 
3%, mortality around 2.1% and 5-year prevalence 
around 22.07% [2]. In India, bladder cancer ranks at 17th 
position with incidence 1.6%, mortality 1.3% and 5-year 
prevalence around 3.57% [3]. In developed countries, 
Squamous cell carcinoma of the bladder is a rare cause of 
bladder cancer with accountability of 2.7% of all bladder 
cancer cases [4]. Around 59% of bladder cancer cases are 
caused by schistosomiasis where it is endemic [5]. The sub-
classification of squamous cell carcinoma of the bladder 
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We are reporting a case of urothelial bladder cancer in a 36 year old male 
patient with no history or exposure to any risk factors. The incidence of 
urothelial bladder cancer is very low in young individuals i.e. below 40 
years of age with reported rate of incidence around 0.1-0.4 %. Most of the 
times, these young individuals present with non-muscle invasive bladder 
cancer with low grade and low stage. As the age increases, the incidence 
of high grade bladder cancer increases along with it. The index case 
presented with high grade muscle invasive bladder cancer at the time of 
diagnosis without any known risk factors. The 5-year survival of urothelial 
bladder cancer is better in young patients (93.8 %) as compared to older 
people(85.1 %). Cigarette smoking is responsible for development of 
bladder cancer in majority of patients followed by exposure to occupational 
carcinogens. Role of genetic alterations in development of bladder cancer 
is still under research and process of urothelial bladder carcinogenesis is 
unanswered in young individuals.
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causative agent, Schistosomiasis hematobium [6,7]. About 
30% of newly diagnosed bladder cancer patients present 
with muscle invasive bladder cancer (MIBC) or later 
they progress to MIBC [8]. It is extremely rare below 30 
years of age and only limited case studies are reported 
where bladder cancer was diagnosed in young adult and 
paediatric patients [9,10]. Various chemical carcinogens 
have been identified which are responsible for bladder 
cancer, out of which cigarette smoking is responsible for 
near about 50% of cases and 20% of cases are caused by 
occupational exposure [11]. 
2. Case Report
A 36 year old gentleman with no co-morbidty with 
Eastern Cooperative Oncology Group Performance 
Status 1 (ECOG PS - I) presented to our clinic with post 
[TURBT] Trans Urethral Resection of Bladder Tumor 
procedure. He had a history of occasional hematuria for 
the last 15 days. His home town is located in a remote 
village which is far away from the city. He is a farmer 
by occupation and his 3 generations were involved in 
farming business. No relevant family, past, surgical and 
medical history. He had no addiction. He consulted a 
nearby local general practitioner for hematuria and he 
had been advised ultrasound of abdomen with pelvis. 
Ultrasound was suggestive of bladder tumor of size 
3x2 cm at postero-lateral wall of urinary bladder. With 
this report, he had been referred to urologist. Urologist 
advised him to do Contrast Enhanced Computed 
Tomography [CECT] of thorax, abdomen and pelvis. 
CECT picked up a lesion of size 2.8x2.2 cm located at 
left postero-lateral wall of urinary bladder with extension 
at left vesico-uretric junction with no uretric obstruction. 
No pelvic or retroperitoneal lymphadenopathy with no 
distant metastasis. He had been advised TURBT and he 
underwent the procedure. Post TURBT histopathology 
demonstrated a high grade muscle invasive urothelial 
carcinoma with carcinoma in situ component at fundus of 
bladder and prostatic urethra. 
Patient was visited to our clinic with the report. 
Systemic examination was unremarkable. Case was 
discussed in our Institutional Multidisciplinary Tumor 
Board and plan was decided to go ahead with upfront 
surgery. Board advised him a surgical procedure of 
Radical Cysto-prostatectomy with bilateral pelvic lymph 
node dissection with ileal conduit or neo bladder. Patient 
had opted for ileal conduit. He underwent the surgical 
procedure (Figures 1, 2). Prostate was also removed 
along with the specimen as prostatic urethra had focus 
of carcinoma. Ileal conduit was prepared for urinary 
diversion (Figure 3). From 3rd postoperative day, oral 
feeding was started. Post operative course was uneventful 
and he was discharged on 8th postoperative day. Final 
histopathology was suggestive of high grade residual 
urothelia carcinoma of size 2x2 cm with thickness 1 cm 
located at left postero-lateral wall with invasion into the 
serosal fat. Prostate, seminal vesicles, bilateral uretric and 
urethral cut margins were free from tumor and bilateral 
pelvic lymph nodes (right -0/6, left 0/11) were free from 
metastasis. Case was re-discussed in the tumor board 
and adjuvant chemotherapy had been advised to him. 
He had completed chemotherapy without any major 
adverse effects. Now he is in follow up with us as per 
our institutional follow up protocol and after 1 year of 
completion of treatment, he is still disease free.
Figure 1. Radical Cystectomy specimen (Dorsal View)
Figure 2. Radical Cystectomy specimen (Ventral View)
Figure 3. Ileal Conduit with uretric transposition 
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3. Discussion
The incidence of urothelial bladder cancer (UBC) is 
15-20 times higher in people with age above 70 years 
as compared to people with age range between 30-50 
years [12]. The incidence is 15-20 times more in males as 
compared to females [13]. The higher prevalence in males 
is because of smoking habits and higher occupational 
exposure to risk factors [14]. Most of the time, patients with 
UBC present with hematuria which may be painless and 
macroscopic [10]. Hence, there will be a diagnostic delay 
for a period of 6-12 months. Utrasound imaging is reliable 
and most sensitive tool for detecting UBC. Urine cytology 
has very low sensitivity and it carries less important role 
in diagnosing UBC. Computed Tomography is useful in 
assessing upper urinary tract and distant metastatic foci. 
Several case studies reported that UBC below 20 years 
of age has different clinical and pathological features as 
compared to others [11]. As the age increases, the incidence 
of high grade UBC increases along with it and in young 
patients it is low stage and low grade. According to Wang, 
the 5-year survival of UBC is better in young patients 
(93.8%) as compared to older people (85.1%) [15]. The 
index case presented with occasional painless hematuria. 
However, he reported immediately to the treating medical 
team after noticing it and underwent the investigations 
and procedure as suggested.
Several studies were conducted to find out the genetic 
alterations responsible for development of UBC in young 
patients who does not have any risk factors and presented 
with lower stage and low grade tumors. Wild et al [16] 
and Owen et al [17] reported that genetic alterations are 
extremely rare under 20 years of age. The recurrence rate 
of UBC is less in younger individuals as compared to 
elderly people. Na et al. [18] reported the recurrence rate 
of 7.1% in patients below 40 years of age as compared 
to 38% in patients with age above 60 years. Most of 
the young patients present with UBC with non-muscle 
invasive disease with lower progression, low grade and 
lower recurrence rate. Paner et al. demonstrated in his 
review of younger patients with UBC with age below 30 
years, only 3.0% had muscle-invasive disease and only 
1.7% had high-grade tumor [19]. However, aggressive 
bladder cancer has been reported in children - a 31-month-
old and a 14-year-old [20,21]. The index case had no known 
risk factors and he had been diagnosed with high grade 
disease at the time of initial diagnosis.
Cigarette smoking is by far the most prevalent 
risk factor for developing UBC. Polycyclic Aromatic 
Hydrocarbon (PAH) exposure is responsible for 15-
20% of bladder cancer cases. In rest of the cases, other 
occupational carcinogens and genetic alterations are the 
causative agents. Radical cystectomy is the definitive 
curative treatment option for patients with muscle invasive 
bladder cancer, recurrent high grade superficial bladder 
cancer and high-grade T1 disease. In the postoperative 
period, young patients may suffer from infertility and 
impotence. Nerve sparing surgery along with preservation 
of prostate and seminal vesicle should be an option in 
young patients. Neobladder urinary diversion is the 
preferred surgical option which helps in maintaining body 
image and quality of life. In the index case, prostatic 
urethra was involved by the disease, so he underwent 
prostatectomy and he does not have issue of impotency 
in the postoperative period. Thus, it is a rare presentation 
of high grade muscle invasive bladder cancer without any 
known risk factors in a 36 year old gentleman.
4. Conclusions
Bladder cancer oncogenesis is still unclear in young 
adults due to lack of precise research studies. High grade 
muscle invasive bladder cancer is rare below 40 years 
of age and preservation of fertility with maintenance of 
quality of life are prime important factors while doing 
radical cystectomy in young patients.
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